-
Remember Academician Wu Tianyi: There is a plateau at the foot and people in the heart
Time of Update: 2021-07-29
But what few people know is that in order to devote himself to high altitude medical research, he suffered from 14 comminuted fractures, cataracts in both eyes, and punctured eardrums all the year round .
-
The new ED product is here for the first time, and Haisco "Avanafil" will be approved soon
Time of Update: 2021-07-29
Recently, the official website of N MPA showed that Sichuan Haisco Pharmaceutical’s application for the listing of the 3 generic drug avanafil tablets (acceptance number: CYHS1900563/4) has entered the "under review" status and will soon be approved, becoming the first imitation and the first in China.
-
GSK uses "delay fees" to restrict competition and fined how old-brand pharmaceutical companies do it under the patent cliff
Time of Update: 2021-07-29
The plummeting rate of return on investment may be one of the main reasons why the original research drug companies choose to purchase small, streamlined, and potential product pipelines at a high price when their patents expire .
-
New coronavirus infection and genetic factors of the disease are determined for the first time
Time of Update: 2021-07-29
The researchers concluded that this international cooperation has identified new host genetic factors related to the new coronary pneumonia at an unprecedented speed, and will continue to collect data to bring the scale and diversity of the lineage covered by the analysis to a higher level .
-
Yan Ning's team Nature issued an article: Research and development of guiding painkillers
Time of Update: 2021-07-29
This research is the first to analyze the high-definition three-dimensional structure of a human-derived neural tissue N-type voltage-gated calcium ion channel with a resolution of 3.
2+ The voltage-gated calcium channel (Cav) protein family includes 10 members.
-
Xuantai Pharmaceutical Science and Technology Innovation Board IPO application accepted, plans to raise 600 million yuan
Time of Update: 2021-07-29
("Xuantai Pharmaceutical" for short) is a high-tech enterprise driven by R&D and innovation, mainly engaged in the research and development, production and sales of high-end generic drugs and CRO services .
-
Let’s talk about filling liquid capsules
Time of Update: 2021-07-29
Yan, an Internet celebrity in the excipients industry, will bring you the topic of "The Role of Innovative Liquid Filled Hard Capsule Technology in the Development of New Drugs"!
-
Announcement on the issuance of "Chemical Generic Drug Reference Preparation Catalog (Forty-fourth Batch)"
Time of Update: 2021-07-29
According to the "Announcement on the Selection and Determination Procedures for the Publication of Reference Preparations for Chemical Generic Drugs" issued by the National Bureau on March 28, 2019 (No.
docx Annex 2: Application Form for Objection to Chemical Generic Drug Reference Preparation.
-
Newly developed absorbable cardiac pacemakers and wearable nucleic acid biosensors
Time of Update: 2021-07-29
The author of the paper believes that the successful embedding of synthetic biological sensors in wearable fabrics is the first step to create multifunctional smart clothing, which is expected to achieve a wider range of applications such as biomedicine .
-
New research: heat-resistant new crown vaccine formula is effective against mutant strains
Time of Update: 2021-07-29
Researchers said that most of the new crown vaccines need to be refrigerated to maintain their effectiveness.
According to reports, the new vaccine formula can remain stable for more than 4 weeks at 37 degrees Celsius, and can be stored for 90 minutes at 100 degrees Celsius .
-
Notice on Soliciting Opinions on the "Change of Working Procedures During the Review Period of Drug Registration Application"
Time of Update: 2021-07-29
cn June 23, 2021 attachment1 : "Working Procedures for Changes during the Review of Drug Registration Application" (Draft for Solicitation of Comments).
docx Annex 2: Drafting instructions for "Working Procedures for Changes during the Review Period of Drug Registration Application" (Draft for Solicitation of Comments).
-
There is no specific anti-hepatitis E virus, the key lies in prevention
Time of Update: 2021-07-28
Third Affiliated Hospital of Sun Yat-sen, vice liver disease hospital president high Zhiliang, 18, at present there is no anti-hepatitis E virus-specific drugs, the key is prevention .
Elderly people, women of childbearing age, patients with basic liver diseases and other high-risk groups are vaccinated against hepatitis E vaccine .
-
Delta mutant strains have appeared in at least 98 countries and regions
Time of Update: 2021-07-28
This mutant strain is more dangerous and continues to mutate and evolve.
-
The drug review report is out!
Time of Update: 2021-07-28
Priority review approved doubled The report also shows that in 2020, the Center for Drug Evaluation will complete 11,582 registration applications for Chinese medicines, chemical drugs, and biological products (including 4 device combination products, counted by acceptance numbers), an increase of 32.
-
Health Commission: 22 new cases were confirmed on the 4th, including 3 local cases
Time of Update: 2021-07-28
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 4 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 4 The lat
-
Hengrui Medicine's CDK 4/6 inhibitor listing application plans to be included in priority review
Time of Update: 2021-07-28
On May 10, according to the latest announcement by the Drug Evaluation Center of the National Medical Products Administration of China, two marketing applications of Hengrui Medicine's CDK 4/6 inhibitor SHR6390 tablets were included in the list of proposed priority reviews .
-
New malaria vaccine demonstrates high levels of protection in initial trials
Time of Update: 2021-07-28
8%; In the case of being injected with malaria sporozoites combined with chloroquine, this high-dose vaccine will infect Plasmodium xenans after 3 months 100% of the protective effects were achieved on the 6 volunteers .
-
The National Medical Science Foundation of China announced the list of experts for evaluation of four projects including Jie Qing
Time of Update: 2021-07-28
National Natural Science Fund Committee willCommittee member Department of Medical Sciences June 28, 2021
-
Nuocheng Jianhua's new multi-target RTK inhibitor ICP-033 new drug research application was accepted by the State Food and Drug Administration
Time of Update: 2021-07-28
Biomedical high-tech company Nuocheng Jianhua announced that the company's new multi-target receptor tyrosine kinase (RTK) inhibitor ICP-033 New Drug Research (IND) application has been accepted by the National Medical Products Administration (NMPA) .
-
David Hyman: The spread of the new coronavirus is closer to a "natural event"
Time of Update: 2021-07-28
In view of the current mutation of the new crown virus in many countries and regions in the world, cooperation between countries and the leadership of authoritative international organizations are particularly important .
